Drug Launch Strategy Analysis: Success Story of Identifying First Launch, Timelines, and Geographies Through Primary Intelligence

A Germany-based mid-sized pharma company actively engaged in the late-stage development of a therapy for Primary Immunodeficiency (PID) and, with a strong marketing and drug commercialization presence in Europe, sought to assess the launch readiness of competitors to position its product…